{"id":827384,"date":"2025-03-19T07:35:02","date_gmt":"2025-03-19T11:35:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/"},"modified":"2025-03-19T07:35:02","modified_gmt":"2025-03-19T11:35:02","slug":"collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/","title":{"rendered":"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Conference call to be held on Wednesday, March 26, 2025<\/span> at 10:00 a.m.<\/span> U.S. EST<\/i>\n <\/p>\n

\n REHOVOT, Israel<\/span><\/span>, March 19, 2025<\/span><\/span> \/PRNewswire\/ — CollPlant Biotechnologies (Nasdaq:\u00a0 CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025<\/span>, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its financial results and corporate updates on Wednesday, March 26<\/span>th<\/sup> at 10:00 a.m. Eastern Standard Time<\/span>.<\/span><\/p>\n

\u00a0<\/p>\n

\n \"CollPlant\n <\/div>\n

\u00a0<\/p>\n

\n Conference call information<\/b>\n <\/p>\n

To participate in the conference call, please use the dial-in information below:<\/p>\n

\n U.S. investors: 1-877-407-9716\u00a0
<\/b>
\n Investors outside of the U.S.: 1-201-493-6779\u00a0
<\/b>
\n
\n Israel<\/span> investors: 1-809-406-247
<\/b>
\n Conference ID: 13750725<\/b>\n <\/p>\n

\n Note, you can avoid long wait times for the operator by using the Call me\u2122 feature and clicking the link below 15 minutes prior to the scheduled call start time:<\/i>\n <\/p>\n

\n https:\/\/callme.viavid.com\/viavid\/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6<\/a>\n <\/p>\n

\u00a0<\/p>\n

\u00a0<\/p>\n

\n Webcast information\u00a0<\/b>\n <\/p>\n

A live audio only webcast will also be available in listen-only mode and \u00a0can be accessed here<\/a>\u00a0or via the link to be posted on the News & Events<\/a> section of the CollPlant Investor relations website. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website for a limited time.<\/p>\n

\n
\n Submit questions to management in advance of the call<\/i>
\n <\/b>\n <\/p>\n

To ask management a question ahead of the call, please email Dan Ferry<\/span> at LifeSci Advisors, LLC up until 24 hours before the event at daniel@lifesciadvisors.com<\/a>.<\/p>\n

\n About CollPlant<\/b>\n <\/p>\n

CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on medical aesthetics and 3D bioprinting of tissues and organs. The Company’s products are based on its rhCollagen (recombinant human collagen) produced with CollPlant’s proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.<\/p>\n

In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.<\/p>\n

For more information about CollPlant, visit\u00a0http:\/\/www.collplant.com<\/a><\/p>\n

\n Contacts<\/b>\n <\/p>\n

\n\n\n\n\n\n\n
\n

\n
\n
\n CollPlant:\u00a0\u00a0\u00a0\u00a0 <\/span>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n Investor:<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Eran Rotem\u00a0\u00a0 <\/span>\n <\/p>\n<\/td>\n

\n

\n Daniel Ferry<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Deputy CEO & CFO<\/span>\n <\/p>\n<\/td>\n

\n

\n Managing Director<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Tel: +972-73-2325600\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n LifeSci Advisors, LLC<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n Email: eran@collplant.com<\/a>\u00a0\u00a0\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n daniel@lifesciadvisors.com<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

Logo – https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information-302405677.html<\/a><\/p>\n

SOURCE CollPlant<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST REHOVOT, Israel, March 19, 2025 \/PRNewswire\/ — CollPlant Biotechnologies (Nasdaq:\u00a0 CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its financial results and corporate updates on Wednesday, March 26th at 10:00 a.m. Eastern Standard Time. \u00a0 \u00a0 Conference call information To participate … <\/p>\n

Continue reading “COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-827384","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST REHOVOT, Israel, March 19, 2025 \/PRNewswire\/ — CollPlant Biotechnologies (Nasdaq:\u00a0 CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its financial results and corporate updates on Wednesday, March 26th at 10:00 a.m. Eastern Standard Time. \u00a0 \u00a0 Conference call information To participate … Continue reading "COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-19T11:35:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION\",\"datePublished\":\"2025-03-19T11:35:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/\"},\"wordCount\":465,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2217353\\\/CollPlant_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/\",\"name\":\"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2217353\\\/CollPlant_Logo.jpg\",\"datePublished\":\"2025-03-19T11:35:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2217353\\\/CollPlant_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2217353\\\/CollPlant_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/","og_locale":"en_US","og_type":"article","og_title":"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Market Newsdesk","og_description":"PR Newswire Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST REHOVOT, Israel, March 19, 2025 \/PRNewswire\/ — CollPlant Biotechnologies (Nasdaq:\u00a0 CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its financial results and corporate updates on Wednesday, March 26th at 10:00 a.m. Eastern Standard Time. \u00a0 \u00a0 Conference call information To participate … Continue reading \"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-19T11:35:02+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION","datePublished":"2025-03-19T11:35:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/"},"wordCount":465,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/","name":"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg","datePublished":"2025-03-19T11:35:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2217353\/CollPlant_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collplant-biotechnologies-announces-date-for-2024-fourth-quarter-and-full-year-2024-financial-results-and-conference-call-information\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/827384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=827384"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/827384\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=827384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=827384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=827384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}